Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1454 ARTÍCULOS , VIENDO DEL 556 AL 570

Imaging markers of structural and functional brain changes that precede cognitive symptoms in risk for Alzheimer's disease

Burggren A, Brown J.

Brain Imaging Behav. 2014 Jun;8(2):251-61. doi: 10.1007/s11682-013-9278-4.

Accuracy of urinary AD7c-NTP for diagnosing Alzheimer's disease: a systematic review and meta-analysis

Zhang J, Zhang CH, Li RJ, Lin XL, Chen YD, Gao HQ, Shi SL.

J Alzheimers Dis. 2014;40(1):153-9. doi: 10.3233/JAD-131445.

[The influence of long-term care on the health of caregivers of Alzheimer's disease patients]

Rachel W, Datka W, Zyss T, Zięba A.

Przegl Lek. 2014;71(12):703-6.

A phase1 study of stereotactic gene delivery of AAV2-NGF for Alzheimer's disease

Rafii MS, Baumann TL, Bakay RA, Ostrove JM, Siffert J, Fleisher AS, Herzog CD, Barba D, Pay M, Salmon DP, Chu Y, Kordower JH, Bishop K, Keator D, Potkin S, Bartus RT.

Alzheimers Dement. 2014 Sep;10(5):571-81. doi: 10.1016/j.jalz.2013.09.004. Epub 2014 Jan 7.

Is synaptic loss a unique hallmark of Alzheimer's disease?

Scheff SW, Neltner JH, Nelson PT.

Biochem Pharmacol. 2014 Apr 15;88(4):517-28. doi: 10.1016/j.bcp.2013.12.028. Epub 2014 Jan 9.

A novel PSEN1 mutation (I238M) associated with early-onset Alzheimer's disease in an African-American woman

Ting SK, Benzinger T, Kepe V, Fagan A, Coppola G, Porter V, Hecimovic S, Chakraverty S, Alvarez-Retuerto AI, Goate A, Ringman JM.

J Alzheimers Dis. 2014;40(2):271-5. doi: 10.3233/JAD-131844.

Open-label, short-term, repetitive transcranial magnetic stimulation in patients with Alzheimer's disease with functional imaging correlates and literature review

Devi G, Voss HU, Levine D, Abrassart D, Heier L, Halper J, Martin L, Lowe S.

Am J Alzheimers Dis Other Demen. 2014 May;29(3):248-55. doi: 10.1177/1533317513517047. Epub 2014 Jan 13.

[Long-term antipsychotics for patients with dementia - discontinue or continue treatment?]

Renard D, de Pélichy E, von Elm E.

Praxis (Bern 1994). 2014 Jan 15;103(2):109-10. doi: 10.1024/1661-8157/a001543.

Emotional and behavioral symptoms in neurodegenerative disease: a model for studying the neural bases of psychopathology

Levenson RW, Sturm VE, Haase CM.

Annu Rev Clin Psychol. 2014;10:581-606. doi: 10.1146/annurev-clinpsy-032813-153653. Epub 2014 Jan 15.

Accuracy of cerebrospinal fluid Aβ(1-42) for Alzheimer's disease diagnosis: a systematic review and meta-analysis

Rosa MI, Perucchi J, Medeiros LR, Fernandes B, Fernandes Dos Reis ME, Silva BR.

J Alzheimers Dis. 2014;40(2):443-54. doi: 10.3233/JAD-132264.

A Novel Presenilin 1 Mutation in Early-Onset Alzheimer's Disease With Prominent Frontal Features

Nygaard HB, Lippa CF, Mehdi D, Baehring JM.

Am J Alzheimers Dis Other Demen. 2014 Aug;29(5):433-5. doi: 10.1177/1533317513518653. Epub 2014 Jan 24.

[Recommendations for diagnosis and therapy of behavioral and psychological symptoms in dementia (BPSD)]

Savaskan E, Bopp-Kistler I, Buerge M, Fischlin R, Georgescu D, Giardini U, Hatzinger M, Hemmeter U, Justiniano I, Kressig RW, Monsch A, Mosimann UP, Mueri R, Munk A, Popp J, Schmid R, Wollmer MA.

Praxis (Bern 1994). 2014 Jan 29;103(3):135-48. doi: 10.1024/1661-8157/a001547.

Butyrylcholinesterase K and apolipoprotein ε4 affect cortical thickness and neuropsychiatric symptoms in Alzheimer's disease

Yoo HB, Lee HW, Shin S, Park SW, Choi JS, Jung HY, Cha J, Lee JM, Lee JY.

Curr Alzheimer Res. 2014 Feb;11(2):137-44. doi: 10.2174/1567205011666140130152114.

Brain stem hemorrhage due to cerebral amyloid angiopathy: the autopsy of a patient with Alzheimer's disease at a young age

Ohtani S, Shimizu K, Asari M, Maseda C, Oka K, Yamada H, Hoshina C, Doi H, Yajima D, Shiono H, Ogawa K.

Leg Med (Tokyo). 2014 Mar;16(2):98-101. doi: 10.1016/j.legalmed.2014.01.003. Epub 2014 Jan 17.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias